Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function

ClinicalTrials.gov ID: NCT02296905

Public ClinicalTrials.gov record NCT02296905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jun 25, 2026, 5:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT02296905
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: AbbVie; Industry
Enrollment: 24 participants

Conditions and interventions

Conditions

Hepatic Impairment

Interventions

ABT-493 Drug
ABT-530 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2014
Primary completion: Aug 31, 2015
Completion: Aug 31, 2015
Last update posted: Oct 20, 2015

2014 – 2015

United States locations

U.S. sites: 3
U.S. states: 2
U.S. cities: 3

Facility	City	State	ZIP	Site status
Site Reference ID/Investigator# 130589	Miami	Florida	33136	—
Site Reference ID/Investigator# 130591	Orlando	Florida	32809	—
Site Reference ID/Investigator# 130588	San Antonio	Texas	78215	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02296905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 20, 2015 · Synced Jun 25, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02296905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →